Table 3.
Clinical data and biochemical results for AKI and non-AKI COVID-19 patients.
| Hospitalized patients | AKI | Non-AKI | p |
|---|---|---|---|
| N, % | 15 (7.5%) | 184 (92.5%) | < 0.001 |
| Age (years) | 64.1 ± 20.2 | 58.5 ± 15.9 | 0.250 |
| DM (n, %) | 4/15 (26.7) | 23/184 (12.5) | 0.014 |
| HT (n, %) | 11/15 (73.3) | 64/184 (34.8) | < 0.001 |
| Obesity (n, %) | 5/15 (33.3) | 14/184 (7.6) | 0.001 |
| CKD (n, %) | 4/15 (26.7) | 11/184 (6.0) | 0.004 |
| HF (n, %) | 0/15 (0.0) | 1/184 (0.5) | 0.772 |
| ICU (n, %) | 4/15 (26.7) | 20/184 (10.9) | 0.004 |
| Non-survivors (n, %) | 5/15 (33.3) | 15/184 (8.2) | < 0.001 |
| Significant parameters | |||
| Male (n, %) | 11/15 (73.3) | 110/184 (59.8) | 0.049 |
| Urine pH | 5.5 (1.0) | 6.0 (1.0) | 0.017 |
| Urine blood presence (n, %) | 5/15 (33.3) | 14/184 (7.6) | 0.001 |
| Urine protein presence (n, %) | 14/15 (83.3) | 128/184 (69.6) | 0.030 |
| Urine Nitrite positive (n, %) | 2/15 (13.3) | 5/184 (2.7) | 0.032 |
| Serum creatinine (mg/dL) | 1.38 (0.90) | 0.82 (0.27) | 0.013 |
| Serum Chloride (mmol/L) | 106 (9) | 104 (6) | 0.017 |
| Serum urate (mg/dL) | 6.2 (2.3) | 4.2 (2.0) | 0.003 |
Quantitative variables were described by mean ± standard deviation or median (IQR); AKI, Acute Kidney Injury; DM, Diabetes; HT, Hypertension; CKD, Chronic kidney disease; HF, heart failure; ICU, Intensive Care Unit.